Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | 0.002 | 0 | 0.5 |
Echinococcus granulosus | histone h3 methyltransferase | 0.0155 | 1 | 0.5 |
Leishmania major | histone-lysine N-methyltransferase, putative | 0.002 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0064 | 0.3278 | 0.2658 |
Brugia malayi | SEA domain containing protein | 0.0064 | 0.3278 | 0.3078 |
Trypanosoma brucei | histone-lysine n-methyltransferase | 0.002 | 0 | 0.5 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.0064 | 0.3278 | 0.3078 |
Trypanosoma cruzi | Histone methylation protein DOT1, putative | 0.002 | 0 | 0.5 |
Onchocerca volvulus | 0.0064 | 0.3278 | 0.5 | |
Toxoplasma gondii | hypothetical protein | 0.002 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0064 | 0.3278 | 0.3078 |
Echinococcus multilocularis | histone h3 methyltransferase | 0.0155 | 1 | 0.5 |
Brugia malayi | Muscle positioning protein 4 | 0.0064 | 0.3278 | 0.3078 |
Trypanosoma cruzi | Histone-lysine N-methyltransferase, H3 lysine-76 specific | 0.002 | 0 | 0.5 |
Onchocerca volvulus | 0.0064 | 0.3278 | 0.5 | |
Trypanosoma cruzi | Histone methylation protein DOT1, putative | 0.002 | 0 | 0.5 |
Schistosoma mansoni | histone J3 methyltransferase | 0.0155 | 1 | 1 |
Trypanosoma cruzi | histone-lysine N-methyltransferase, putative | 0.002 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0064 | 0.3278 | 0.3078 |
Leishmania major | hypothetical protein, conserved | 0.002 | 0 | 0.5 |
Trypanosoma brucei | Histone-lysine N-methyltransferase, H3 lysine-76 specific | 0.002 | 0 | 0.5 |
Onchocerca volvulus | 0.0064 | 0.3278 | 0.5 | |
Trypanosoma brucei | Histone methylation protein DOT1, putative | 0.002 | 0 | 0.5 |
Onchocerca volvulus | 0.0064 | 0.3278 | 0.5 | |
Onchocerca volvulus | 0.0064 | 0.3278 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | > 50 uM | Competitive inhibition of recombinant human DOT1L using adenosine/deazaadenosine as substrate and SAM cofactor | ChEMBL. | 23879463 |
Ki (binding) | > 50 uM | Inhibition of SUV39H1 (unknown origin) | ChEMBL. | 23795283 |
Ki (binding) | > 50 uM | Inhibition of CARM1 (unknown origin) | ChEMBL. | 23795283 |
Ki (binding) | > 50 uM | Inhibition of human recombinant DOT1L (catalytic domain 1 to 472) using [3H]-SAM by scintillation containing | ChEMBL. | 23795283 |
Ki (binding) | > 50 uM | Inhibition of PRMT1 (unknown origin) | ChEMBL. | 23795283 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.